CAS 79714-31-1

Risarestat

Description:

Risarestat, identified by the CAS number 79714-31-1, is a chemical compound that belongs to the class of pharmacological agents known as aldose reductase inhibitors. It is primarily investigated for its potential therapeutic applications in managing diabetic complications, particularly diabetic neuropathy and retinopathy, by inhibiting the enzyme aldose reductase, which is involved in the conversion of glucose to sorbitol. This action helps to reduce the accumulation of sorbitol and fructose, which can lead to osmotic and oxidative stress in cells. Risarestat is characterized by its specific molecular structure, which contributes to its biological activity. The compound is typically administered in a controlled dosage form, and its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are crucial for determining its efficacy and safety profile. As with many pharmacological agents, ongoing research continues to explore its full potential and any associated side effects.

Formula: C₁₆H₂₁NO₄S

InChI: InChI=1S/C16H21NO4S/c1-3-5-6-9-21-12-8-7-11(10-13(12)20-4-2)14-15(18)17-16(19)22-14/h7-8,10,14H,3-6,9H2,1-2H3,(H,17,18,19)

InChI key: InChIKey=CRPGRUONUFDYBG-UHFFFAOYSA-N

SMILES: O=C1C(C2=CC(OCC)=C(OCCCCC)C=C2)SC(=O)N1

Synonyms:

• CT 112 (reductase inhibitor)
• Risarestat
• 2,4-Thiazolidinedione, 5-[3-ethoxy-4-(pentyloxy)phenyl]-
• 5-[3-Ethoxy-4-(pentyloxy)phenyl]-2,4-thiazolidinedione
• CT 112

Risarestat

CAS: 79714-31-1

Risarestat is a drug that inhibits the degradation of celluloses in patients with metabolic disorders. It also inhibits the production of lactic acid in chronic bronchitis and other respiratory disorders. Risarestat prevents the formation of carbonyl groups by inhibiting their synthesis by means of an unknown mechanism. The drug can be used as a pharmaceutical dosage for diabetes, but it is not active against bacterial infections. The polymer has a particle size of less than 100 nm and is biocompatible. It contains benzalkonium chloride, which makes it resistant to bacterial growth and suitable for use in chronic bronchitis.

Formula: C₁₆H₂₁NO₄S

Purity: Min. 95%

Molecular weight: 323.4 g/mol

Ref: 3D-EDA71431

Risarestat

CAS: 79714-31-1

Risarestat (CT-112) is a potent aldose reductase inhibitor and thyroid hormone receptor (TR) antagonist for the treatment of hypoglycemia.

Formula: C₁₆H₂₁NO₄S

Purity: 98.39%

Color and Shape: Solid

Molecular weight: 323.41

Ref: TM-T16756